O67.0 Intrapartum hemorrhage with coagulation defect

Name of the Condition

• Intrapartum Hemorrhage with Coagulation Defect
• ICD-10 Code: O67.0

Summary

Intrapartum hemorrhage with coagulation defect refers to excessive bleeding during labor and delivery that is complicated by an underlying coagulation disorder. This condition poses risks to maternal and fetal well-being and requires prompt recognition and management to prevent severe outcomes.

Causes

Intrapartum hemorrhage with coagulation defect may result from pre-existing coagulation disorders, such as hemophilia or von Willebrand disease, or acquired conditions like disseminated intravascular coagulation (DIC) triggered by obstetric complications. Trauma during delivery or placental abnormalities can also exacerbate bleeding in the presence of coagulation defects.

Risk Factors

• Pre-existing coagulation disorders (e.g., inherited bleeding disorders)
• Severe preeclampsia or eclampsia
• Placental abruption or previa
• Prolonged labor or instrumental delivery
• History of bleeding disorders or thrombocytopenia
• Use of anticoagulant medications during pregnancy

Symptoms

• Excessive or uncontrolled vaginal bleeding during labor
• Persistent oozing from incision sites or mucous membranes
• Signs of shock (e.g., hypotension, tachycardia, pallor)
• Petechiae or bruising unrelated to trauma
• Prolonged or excessive bleeding post-delivery

Diagnosis

Diagnosis involves clinical assessment of bleeding patterns, vital sign monitoring, and laboratory testing to evaluate coagulation status (e.g., PT, aPTT, fibrinogen levels, platelet count). Imaging may be used to identify sources of bleeding, such as placental abnormalities or uterine trauma.

Treatment Options

• Immediate administration of blood products (e.g., platelets, fresh frozen plasma, cryoprecipitate) to correct coagulation defects
• Uterotonic medications (e.g., oxytocin, tranexamic acid) to promote uterine contraction and reduce bleeding
• Surgical interventions (e.g., uterine compression, hysterectomy) for refractory hemorrhage
• Management of underlying causes (e.g., treating DIC or discontinuing anticoagulants)

Prognosis and Follow-Up

Prognosis depends on the severity of bleeding, timeliness of treatment, and resolution of coagulation abnormalities. Close monitoring for recurrent bleeding or complications is essential. Follow-up may include repeat coagulation testing and evaluation for underlying disorders.

Complications

• Severe maternal hemorrhage requiring transfusion or surgery
• Disseminated intravascular coagulation (DIC)
• Organ dysfunction (e.g., renal failure, hepatic impairment)
• Fetal distress or hypoxia
• Maternal or perinatal mortality in severe cases

Lifestyle & Prevention

• Preconception counseling for individuals with known coagulation disorders to optimize management before pregnancy
• Prenatal screening for coagulation abnormalities in high-risk cases
• Avoidance of medications that impair coagulation (e.g., NSAIDs) unless medically necessary
• Prompt treatment of obstetric complications to reduce hemorrhage risk

When to Seek Professional Help

Seek immediate medical attention if experiencing heavy or uncontrolled bleeding during labor, signs of shock, or persistent oozing from incision sites. Early intervention is critical to prevent life-threatening complications.

Tips for Medical Coders

Document the presence of a coagulation defect and its contribution to intrapartum hemorrhage. Ensure clinical notes specify the type of coagulation abnormality (e.g., inherited disorder, DIC) and its impact on bleeding severity. Code O67.0 is appropriate when hemorrhage during labor is directly associated with a coagulation defect.